comparemela.com

Page 2 - Icon Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Two Biotechs Uncloak to Deliver Affordable Biological Tools and Fight Dry Eye Disease

Nodexus and Aramis Biosciences will use their funds to expand their company’s pipeline and build their commercialization capabilities.

United statesKarthik balakrishnanAramis biosciencesDavids tierneyReza danaIcon bioscience incNodexus incDrug administrationAramis biosciences incEyepoint pharmaceuticals incBiopharmx corporationBoston based aramis biosciencesIcon bioscienceEyepoint pharmaceuticalsWo biotechs uncloak to deliver affordable biological tools and fight dry eye disease

Aramis Biosciences Launches to Address Unmet Needs in

Founded by Renowned Experts in Ophthalmology and Immunology Launches with $10.5 million Series A Financing Led by Safar Partners to Advance.

United statesMassachusetts institute of technologySunil chauhanAramis bioAramis biosciencesReza danaGuido romeoMarcello allegrettiAramis bioscienceDavids tierneyClaes dohlmanIcon bioscience incHead corporate communicationsOphthalmology at harvard medical schoolScientific coBiopharmx corporation

vimarsana © 2020. All Rights Reserved.